July 31, 2021    ,

3rd Webinar on Hematology

slider
July 31, 2021   10:00 AM GMT  
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
  

3rd Webinar on Hematology

Fundamental research and innovation in Hematology

Briefly Know About This Event

3rd Webinar on Hematology and Genetic Blood Disorders will be hosted on July 31, 2021 as per UK Time Zone (GMT+1). Panel of speakers will be delivering their presentations on their recent research related to Hematology and Genetic Blood Disorders. The current state of knowledge, its impact on the future will be discussed in detailed. Longdom Conferences invites all experts to be part of this webinar series and make it a perfect platform for knowledge sharing and networking.

Main theme of the webinar is Forefront fundamental research and innovation in Hematology

  •  

Sessions

A blood cell disorder is a condition in which there is a problem with our red blood cells, white blood cells, or the smaller circulating cells called platelets, which are critical for clot formation. All cell types form in the bone marrow, which is the soft tissue inside our bones. Red blood cells carry oxygen to our body’s organs and tissues. White blood cells help our body fight infections. Platelets help our blood to clot. Blood cell disorders damage the formation and function of one or more of these types of blood cells. Some symtoms include:

Hemostasis is the cessation of bleeding from a cut or severed vessel, whereas thrombosis occurs when the endothelium lining blood vessels is damaged or removed. These processes involve blood vessels, Plasma protein, and platelet aggregation that cause formation or dissolution of platelet aggregates and fibrin.

In hemostasis, there is initial vasoconstriction of the injured vessel, resulting in diminished blood flow distal to the injury. 

A blood transfusion is a way of adding blood to our body after an illness or injury. If our body is missing one or more of the components that make up healthy blood, a transfusion can help supply what our body is missing. Depending on how much blood we need, a transfusion can take between 1 and 4 hours.

Our blood is made up of several different parts including red and white cells, plasma, and platelets. “Whole blood” refers to blood that has all of them. In some cases, we may need to have a transfusion that uses whole blood, but it’s more likely that we will need a specific component.

Cardiovascular problems through blood and therefore the system that gives laboratory values regarding blood, the circulatory system and secures  cardiovascular diseases from the Chinese medicine and western medicine perspectives.

Cardio-Oncology is to seek out a balance between oncologic efficacy and reducing antagonistic cardiovascular results over timely publication and broadcasting of research. Cardiac imaging and transthoracic echocardiography play an important role within the baseline assessment and serial follow-up of cardio-oncology patients. Scientific indication in the administration of cardiovascular jerks of onco-hematological patients is unusual, as these patients have been systematically omitted from clinical trials and up-to-date approvals are based on expert consent. Cardio-hematology which permit its claim in regular clinical preparation so to market the expansion of local multidisciplinary crews, to rally the cardiovascular health of patients with cancer.

The crossing point between hematology and neurology is broad, and neurological complications within the course of hematologic ailment are recurrent and diverse. Polycythaemia, in which there are increased numbers of red blood cells with iron deficient. Polycythaemia and therefore the comparative Sideropenia cause amplified blood viscosity with connected neurological symptoms and signs. Haematological conditions that lead into neurological manifestations are Thrombophilia, antiphospholipid antibody syndrome, thrombotic thrombocytopenic purpura, sickle cell, myeloma, leukemias, lymphomas and clonal disorders. These are considered into amiable and malignant situations

Immunohematology is the study of reactions that take place between antigens present on blood cells and antibodies present in plasma. Patients undergoing transfusion therapy are tested for their ABO and RhD blood groups and the presence of any antibodies that may create a reaction between their plasma and donor red cells. A range of tests are available to use to detect and identify antibodies in the patient's plasma from simple tube and gel tests to more complex absorption and elution techniques as well as advanced molecular techniques. These same tests will also identify if the antigen is present on the patient's red cells. For patients with hematological conditions such as auto immune hemolytic anemia, a wide range of immune-hematological techniques are used to identify and resolve the diagnostic problems in these patients. Molecular techniques are increasingly used in immunohematology to determine the antigen profile of patients, resolve complex problems and large scale red cell typing.

Our Brilliant Speakers

LONGDOM conferences speaker bureau map future challenges through ideation sessions by designing and validating new ideas with end users by placing right speakers in front of right audience at the right time.

What Client's Say

We let our ground-breaking work and our amazing clients speak for us…… LONGDOM conferences

  [email protected]
  [email protected]
  [email protected]
Speakers Interview